about
Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex.Quinolinic acid, the inescapable neurotoxinCrystal structure of human kynurenine aminotransferase II, a drug target for the treatment of schizophreniaIndoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampusProtective actions of ovarian hormones in the serotonin system of macaquesThe excitotoxin quinolinic acid induces tau phosphorylation in human neuronsThe biochemical pathways of central nervous system neural degeneration in niacin deficiency.Crystal structure of the Anopheles gambiae 3-hydroxykynurenine transaminaseDecreased cortical serotonin in neonatal rabbits exposed to endotoxin in uteroA biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase.Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies.Lack of association between autism and four heavy metal regulatory genes.Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity.Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior.Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis.The tryptophan oxidation pathway in mosquitoes with emphasis on xanthurenic acid biosynthesisGenetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.Promotion of cellular NAD(+) anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer's disease.Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic TargetsMechanism of acute tryptophan depletion: is it only serotonin?The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications.Effects of Kynurenine Pathway Inhibition on NAD Metabolism and Cell Viability in Human Primary Astrocytes and Neurons.Effects of Kynurenine Pathway Metabolites on Intracellular NAD Synthesis and Cell Death in Human Primary Astrocytes and Neurons.TDO as a therapeutic target in brain diseases.Identification and biochemical characterization of the Anopheles gambiae 3-hydroxykynurenine transaminase.Structure of the PLP-Form of the Human Kynurenine Aminotransferase II in a Novel Spacegroup at 1.83 Å Resolution.Characterisation of the kynurenine pathway in skin-derived fibroblasts and keratinocytes.Neuropsychiatric side-effects of interferon-alpha treatment: pathophysiology and therapeutic options.Kynurenine Pathway in Skin Cells: Implications for UV-Induced Skin DamageThe serotonin precursor 5-hydroxytryptophan delays neuromuscular disease in murine familial amyotrophic lateral sclerosis.IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.Reduced serotonin and 3-hydroxyanthranilic acid levels in serum of cystatin B-deficient mice, a model system for progressive myoclonus epilepsy.Association between single nucleotide polymorphisms of TPH1 and TPH2 genes, and depressive disorders.Human kynurenine aminotransferase II - reactivity with substrates and inhibitors
P2860
Q24814135-FFBC00CA-A3F5-436E-AD65-06CCFB3D2D89Q26991715-753EA864-CA02-47C4-933C-5AF7814C975AQ27649208-3222E911-962D-4F44-AA59-E6AA612435DDQ28260918-A15C95D7-C22A-4CBE-AFEC-A6D78B081ED0Q33435072-3E7E802B-7814-4542-BBDA-3E2729968AF6Q33485236-6C8A8958-7AFD-496C-B42A-E47244A5F7D6Q34443624-D5A37F94-349A-4473-B695-BC9DFFA09811Q34595893-A78CF2AC-7F56-4E77-903C-2350EB6880FBQ34627661-DAF8C991-69B5-44DD-93BB-F44CFE6A8168Q34631232-FE88C4D3-13F7-4FE3-A964-0B7DC9CDC3E5Q34997869-9C8072F2-1CBF-4653-85E9-1EA7D01D5AE6Q35501612-2C548EAE-2F03-45D7-8B97-E9BE776C1D30Q35857994-9358E106-878C-4271-8BD3-D519A4337DD9Q35995176-244623C7-6DAF-4412-B2BD-1E057AC6B269Q36565671-40229203-8DB9-430A-A249-370150478B86Q36637156-C7359AE6-F456-4C23-8719-2AC288962235Q37031204-AAD03C0C-1882-4196-8360-6646774E44D9Q37181486-88B6ED0E-0558-4CF8-9E5A-70485D0CD189Q37310546-1CD363E5-4764-4A6F-A1A8-F97FEA38F155Q37845644-46666CCF-7D47-4363-AE5B-BFA034BC75F8Q37977023-4FEF3AD0-B39C-4DB2-B3DA-CCC5437C4DD1Q38728529-108501DF-0CE9-4B28-A1EF-888ED6CC983FQ38728657-E999EA2A-51B5-44BA-8D8F-2FD67AC879FBQ38806660-FF5D94D9-F304-4AFA-B0DC-E4A9B4AB3B70Q40495003-EFAAAFF6-5AF1-477F-9728-5D2C1496115AQ40749076-1D3D46D5-0D4F-4F60-AB45-92EEC74F0476Q41499706-1D92F6FD-00BE-4B79-A32D-DA8EC8B3BAACQ42029245-F2A30B2D-E8DE-4B08-BD32-FCB5C7C95DCFQ42037158-C22604A7-BD2B-445E-A59F-702B30C7AD94Q44607582-08CF9B7D-F7E2-4793-B535-AD4B763EDB4CQ45115322-5DA01430-EFD4-4C77-B6B3-917C6BB56F52Q46574457-7102B2FF-A6A4-48C3-87B6-1D7C84EA275EQ47660714-C9EFB8D5-0D36-4D05-8E92-D382194D9B24Q53408140-794A9A62-8BE5-4D9D-8D9B-749D7CA3D86B
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Endogenous neurotoxins from tryptophan.
@ast
Endogenous neurotoxins from tryptophan.
@en
type
label
Endogenous neurotoxins from tryptophan.
@ast
Endogenous neurotoxins from tryptophan.
@en
prefLabel
Endogenous neurotoxins from tryptophan.
@ast
Endogenous neurotoxins from tryptophan.
@en
P1433
P1476
Endogenous neurotoxins from tryptophan.
@en
P356
10.1016/S0041-0101(00)00156-2
P577
2001-01-01T00:00:00Z